Research: Identification of new drug delivery systems for the Hedgehog/Gli1 inhibitor Glabrescione B in the treatment of Hedgehog-dependent medulloblastoma.
2021: L-2, Bachelor's Degree in Healthcare Biotechnology from the University of Ferrara.
2023: LM-09, Master's Degree in Biotechnology for Personalized Medicine from the Università Cattolica del Sacro Cuore.
From 2024 - ongoing: PhD at the Department of Molecular Medicine, Sapienza University.